Navigation Links
Cardium to Present at the LifeTech Capital Miami Medical Investors Conference
Date:11/8/2010

SAN DIEGO, Nov. 8, 2010 /PRNewswire/ -- Cardium Therapeutics (NYSE Amex: CXM) announced today that Christopher J. Reinhard, Cardium's Chairman and Chief Executive Officer will present at the LifeTech Capital Miami Medical Investors Conference on November 12, 2010 at 2:00 p.m. Eastern.  The conference will take place at the JW Marriott Marquis in Miami.  Although this presentation will not be webcast, investors can access the Company's presentation slides now available at Cardium's website at http://phx.corporate-ir.net/phoenix.zhtml?c=77949&p=irol-presentations.  

(Logo:  http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO)

About Cardium

Cardium is focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses that have the potential to address significant unmet medical needs and definable pathways to commercialization, partnering and other economic monetizations.  Cardium's investment portfolio includes the Tissue Repair Company and Cardium Biologics, medical technology companies primarily focused on the development of innovative therapeutic products for wound healing, bone repair, and cardiovascular indications.  In July 2009, Cardium completed the sale of its InnerCool Therapies medical device business to Royal Philips Electronics, the first asset monetization from the Company's biomedical investment portfolio.  News from Cardium is located at www.cardiumthx.com.

Copyright 2010 Cardium Therapeu
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Cardium Gains Exclusive Access to Novel Polymer-Based Nitric Oxide Technology for Expansion of Wound Healing Product Portfolio
2. Cardium to Present at 10th Annual Biotech in Europe Investor Forum
3. Cardium Regains Listing Compliance With NYSE Amex
4. Cardium to Present at MDB Capital Groups 2010 Bright Lights Conference
5. Cardiums Exchange Listing Compliance Plan Accepted by NYSE AMEX
6. Cardium Reports on Third Quarter 2009 Financial Results and Recent Developments
7. Cardium Announces Plans to File FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Gel for Diabetic, Pressure and Venous Ulcers and Other Topical Wounds
8. Cardium Completes $6.0 Million Registered Direct Offering
9. Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors
10. Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications
11. Cardium Regains Listing Compliance with NYSE Amex
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... PARK, Calif. , Feb. 26, 2015 ... released the latest version of the Governance Portal ... accomplish governance, risk and compliance (GRC) tasks across multiple ... also been updated to help customers better align their ... of the Treadway Commission ) requirements. In response to ...
(Date:2/26/2015)... , Feb. 26, 2015  NuGene International, ... aesthetic products for skin and hair rejuvenation, has ... as agency of record for investor relations and ... improve our distribution, sales and diversification strategies – ... current and prospective shareholders," stated Ali Kharazmi CEO ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 Already well ... gauging line by expanding its Length Gauge offerings with ... gauges. , Specifically, HEIDENHAIN’s pencil probe-style SPECTO ... force specification. Two new 1Vpp, 12mm stroke length ... force applications. One is a variant with a weak ...
(Date:2/26/2015)...  Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a ... are used to develop, manufacture and sell enzymes ... biopharmaceutical and industrial enzyme industries, announced today that ... ending December 31, 2014 after market close on ... conference call that day at 5:00 p.m. Eastern ...
Breaking Biology Technology:Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 2Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 3NuGene International, Inc. Selects Capital Market Relations for Strategic Investor Relations 2NuGene International, Inc. Selects Capital Market Relations for Strategic Investor Relations 3Accuracy and Versatile Gauging Go Hand in Hand at HEIDENHAIN 2Dyadic International To Announce Fourth Quarter 2014 Financial Results And Host Conference Call On Wednesday, March 11, 2015 2Dyadic International To Announce Fourth Quarter 2014 Financial Results And Host Conference Call On Wednesday, March 11, 2015 3
... drugs that,exceeded $20 billion in sales in 2006, that may ... Prescription to OTC switches,were frequent in 2006 and 2007 and ... to OTC Switch: Market Analysis and Product Management,Strategies, predicts this ... are forecast to reach $5 billion in 2008 and,increase by ...
... April 10 Senior experts from PAREXEL,International Corporation ... provider, will discuss best practices for,successful partnerships at ... held April 14-16, 2008 in Las Vegas, Nevada. ... PAREXEL experts will present in the following sessions, ...
... OLDSMAR, Fla., April 10 Cryo-Cell,International, Inc. (OTC ... largest and most established family cord blood banks, ... 29, 2008., Consolidated revenues for the first ... compared to approximately $4.2,million for the first quarter ...
Cached Biology Technology:Use of Rx to OTC Switch as Product Management Tactic Enjoys Comeback 2PAREXEL Experts to Offer Insights Into Outsourcing Best Practices at 17th Annual Partnerships with CROs Conference 2PAREXEL Experts to Offer Insights Into Outsourcing Best Practices at 17th Annual Partnerships with CROs Conference 3PAREXEL Experts to Offer Insights Into Outsourcing Best Practices at 17th Annual Partnerships with CROs Conference 4Cryo-Cell International, Inc. Reports First Quarter 2008 Results 2Cryo-Cell International, Inc. Reports First Quarter 2008 Results 3Cryo-Cell International, Inc. Reports First Quarter 2008 Results 4Cryo-Cell International, Inc. Reports First Quarter 2008 Results 5
(Date:2/24/2015)... 2015 This report analyzes the worldwide markets for ... analytics for the US, Canada , ... Asia-Pacific , Middle East , ... forecasts are provided for the period 2013 through 2020. Also, ... data and analytics are derived from primary and secondary research. ...
(Date:2/23/2015)... Conn. , Feb. 23, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... has filed provisional patent 62114357 for DISTRIBUTED ... this patent, NXT-ID introduces a new groundbreaking payment method. ... the payment account may only be accessed if both ...
(Date:2/13/2015)... 2015 ACT Genomics Co., Ltd., a ... transform cancer genomic information into precision diagnosis and ... raised US$ 8 million in the its first private ... Taipei, Taiwan , ACT Genomics has developed ... aim to implement next generation sequencing (NGS) and ...
Breaking Biology News(10 mins):World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3ACT Genomics Raises $8 Million in its First Private Funding Round 2
... Director of the Lawson Health Research Institute and Professor ... School of Medicine & Dentistry at The University of ... in biology from rebro University in Sweden. ... award and the only recipient this year in the ...
... beliefs, identical twins are not genetically identical. This ... scientists in a study being published today in the ... finding may be of great significance for research on ... methods. How can it be that one identical ...
... growth of pancreatic cancer could lead to a new ... College of Medicine in Houston in a report appearing ... Therapeutics. The protein called mesothelin appears to play ... the senior author Dr. Qizhi (Cathy) Yao, professor of ...
Cached Biology News:Mesothelin engineered on virus-like particles provides treatment clues for pancreatic cancer 2
... 250 ul (125 precipitations). ... easy pellet location.Efficient precipitation ... inert, compatible with most ... protocol. Category: DNA/RNA Synthesis ...
APOPTAG® Plastic Coverslips are designed to be custom fitted to the specific APOPTAG® kit application. Each coverslip has 2.5 x 1 dimensions....
One-step, microplate or cuvet, colorimetric, linear detection range 0.2 mg/dL to 20 mg/dL. Procedure: 20 min....
PEG 8000, Molecular Biology Grade...
Biology Products: